ONEMEDNET CORPORATION Derivative Liability
ONEMEDNET CORPORATION (ONMD) had Derivative Liability of $5.00 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2025-11-14
- 2025-09-30: Derivative Liability $5.00M.
- 2025-03-31: Derivative Liability $5.00K.
- 2024-12-31: Derivative Liability $5.00M; Derivative Liability as first filed $5.00K.
- 2024-06-17: Derivative Liability $5.85K.
| Period end | Derivative Liability | Derivative Liability as first filed |
|---|---|---|
| 2025-09-30 | $5.00M 10-Q · filed 2025-11-14 | |
| 2025-03-31 | $5.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $5.00M 10-Q · filed 2025-11-14 | $5.00K 10-K · filed 2025-04-15 |
| 2024-06-17 | $5.85K 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |